Ori Biotech
Robert Preti is currently an advisor at Ori Biotech. Robert has also served as a director, chief technology officer, and senior vice president of development and manufacturing at Caladrius Biosciences, and as chairman, vice chairman, and member of the board and executive committee of the Alliance for Regenerative Medicine. Prior to that, they were a member of the board of directors of AABB and the chairman, president, CEO, and general manager of Hitachi Chemical Regenerative Medicine Business Sector. Preti began their career as a scientific director in the Clinical Services Division of New York Blood Center.
Robert Preti received their PhD in hematology, cell biology, and metabolism from New York University. Robert also holds a Bachelor of Science in biology from Fordham University.
This person is not in the org chart
This person is not in any offices
Ori Biotech
Ori Biotech is a London- and New Jersey-based innovator in CGT manufacturing that has developed a proprietary, bespoke and flexible manufacturing platform, which enables patient access to a new generation of personalized, life-saving treatments.